ERBB3 signaling was associated with HCC EMT, migration and invasion by either inhibition of miR-296-5p in our previous work 47, or blockade of miR-17-5p/miR-20a-5p in the present work by in vitro and in vivo assay. Here, ERBB3 is linked to hepatocellular carcinoma.